Search
for
Sort by
Research 121–150 of 1000+
- Chemotherapy-Induced Hair Loss and Its Psychological Impacts: A Study Among Cancer Survivors in a Tertiary Care Centre, Chennai
- ANALYSIS OF TRIGGER FACTORS FOR ACUTE TELOGEN HAIR LOSS IN WOMEN OF REPRODUCTIVE AGE
- Alopecia Areata in C3H/HeJ Mice Involves Leukocyte-mediated Root Sheath Disruption in Advance of Overt Hair Loss
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Densitometry and Video-microscopy
- CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?
- Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis
- 199 Computer vision AI-based androgenetic alopecia analysis using a novel mobile web app
- Frontal fibrosing alopecia
- Utility of trichoscopy
- Impact of hormonal disorders after surgical treatment of endocrine pathology on dermatologic status and the need for aesthetic rehabilitation
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- The psychosocial impacts of vitiligo, psoriasis, and alopecia areata on pediatric patients
- Chinese SLE Treatment and Research Group (CSTAR) Registry: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Quantifying Alopecia Areata via Texture Analysis to Automate the SALT Score Computation
- Nanostructured Ayurvedic Emulsion of Bakuchiol & Neem Oil for Mild‑to‑Moderate Alopecia Areata Open‑Label Single‑Arm Pilot Study
- DP10 Scalp disease in dermatomyositis
- Analysis of familial history in Chinese patients with androgenetic alopecia
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Short‐ and Long‐Term Clinical Skin Effects of Testosterone Treatment in Trans Men
- Alopecia areata: A review
- Assessment of clinician-reported outcome measures for alopecia areata: a systematic scoping review
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Factors affecting the severity of central centrifugal cicatricial alopecia